Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Recommendations for preclinical research in hemorrhagic transformation.

Fagan SC, Lapchak PA, Liebeskind DS, Ishrat T, Ergul A.

Transl Stroke Res. 2013 Jun;4(3):322-7. doi: 10.1007/s12975-012-0222-5. Review.

2.

Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.

Wang W, Li M, Chen Q, Wang J.

Mol Neurobiol. 2015 Dec;52(3):1572-1579. doi: 10.1007/s12035-014-8952-x. Epub 2014 Nov 4. Review.

3.

Sonographic evaluation of hemorrhagic transformation and arterial recanalization in acute hemispheric ischemic stroke.

Seidel G, Cangür H, Albers T, Burgemeister A, Meyer-Wiethe K.

Stroke. 2009 Jan;40(1):119-23. doi: 10.1161/STROKEAHA.108.516799. Epub 2008 Nov 6.

4.

Mechanisms and markers for hemorrhagic transformation after stroke.

Rosell A, Foerch C, Murata Y, Lo EH.

Acta Neurochir Suppl. 2008;105:173-8. Review.

PMID:
19066105
5.
6.

Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke.

Moriya Y, Takahashi W, Kijima C, Yutani S, Iijima E, Mizuma A, Honma K, Uesugi T, Ohnuki Y, Nagata E, Yanagimachi N, Takizawa S.

Tokai J Exp Clin Med. 2013 Apr 20;38(1):24-7.

7.

Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model.

Fagan SC, Nagaraja TN, Fenstermacher JD, Zheng J, Johnson M, Knight RA.

Neurol Res. 2003 Jun;25(4):377-82.

PMID:
12870264
8.

Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.

Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.

J Neurol Sci. 2014 Dec 15;347(1-2):148-54. doi: 10.1016/j.jns.2014.09.036. Epub 2014 Sep 28.

PMID:
25292413
9.

Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion.

Lu A, Kurosawa Y, Luskey K, Pyne-Geithman G, Caudell D, Clark J.

Neurol Res. 2009 Mar;31(2):209-14. doi: 10.1179/174313209X393933.

PMID:
19298764
10.
12.

Relation between reperfusion and hemorrhagic transformation in acute ischemic stroke.

Horsch AD, Dankbaar JW, van der Graaf Y, Niesten JM, van Seeters T, van der Schaaf IC, Kappelle LJ, Velthuis BK; DUST investigators.

Neuroradiology. 2015 Dec;57(12):1219-25. doi: 10.1007/s00234-015-1577-6. Epub 2015 Sep 4.

13.

Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.

Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, Xi G.

Stroke. 2007 Apr;38(4):1362-7. Epub 2007 Feb 22.

14.

Prediction of Reperfusion-Associated Hemorrhagic Transformation Using Dynamic Contrast-Enhanced Imaging in a Rat Stroke Model.

Huang WY, Wu G, Li JJ, Geng DY, Tan WL, Yu XR.

J Comput Assist Tomogr. 2015 Sep-Oct;39(5):787-93. doi: 10.1097/RCT.0000000000000283.

PMID:
26196346
15.

Predictors and early outcome of hemorrhagic transformation after acute ischemic stroke.

Kablau M, Kreisel SH, Sauer T, Binder J, Szabo K, Hennerici MG, Kern R.

Cerebrovasc Dis. 2011;32(4):334-41. doi: 10.1159/000331702. Epub 2011 Sep 15.

PMID:
21921596
16.

FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.

Okubo S, Igarashi H, Kanamatsu T, Hasegawa D, Orima H, Katayama Y.

Brain Res. 2007 Apr 27;1143:221-7. Epub 2007 Jan 24.

PMID:
17316578
17.

Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort.

Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, Ringleb AP, Lorenzano S, Manelfe C, Bozzao L.

Stroke. 1999 Nov;30(11):2280-4.

18.

Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.

Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD.

Stroke. 2007 Feb;38(2):313-8. Epub 2007 Jan 4.

20.

High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.

Lapergue B, Dang BQ, Desilles JP, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud PO, Mazighi M, Michel JB, Meilhac O, Amarenco P.

Stroke. 2013 Mar;44(3):699-707. doi: 10.1161/STROKEAHA.112.667832. Epub 2013 Feb 19.

Supplemental Content

Support Center